- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
The Nordic Region’s “Star” Companies
Three companies were crowned the Nordic region’s “shining examples of innovative life science companies” in Stockholm, Sweden, this week.
Three companies were crowned the Nordic region’s “shining examples of innovative life science companies” in Stockholm, Sweden, this week. Nordic Life Science Days, the region’s largest partnering conference, gave its annual Nordic Star Awards to Bone Index (Kuopio, Finland), Lytix Biopharma (Oslo, Norway) and PledPharma (Stockholm, Sweden).
Bone Index was noted for its osteoporosis diagnostic, Bindex, while Lytix Biopharma was rewarded for its results in the field of immuno-oncology. PledPharma was praised for its clinical project platform that targets significant medical needs.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
